Corcept Therapeutics Incorporated
Net Cash Flow Breakdown
Total Cash from Operations: $145.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $413.0K | 0.3% |
| Other Investing | $104.1M | 71.7% |
| Other Financing | $15.8M | 10.9% |
| Working Capital | $24.8M | 17.1% |
| Net Cash Flow | $0 | 0.0% |